Global Predictive Genetic Testing and Consumer Genomics Industry (2020 to 2027) – Key Market Trends and Drivers – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Predictive Genetic Testing and Consumer Genomics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Amid the COVID-19 crisis, the global market for Predictive Genetic Testing and Consumer Genomics estimated at US$4.3 Billion in the year 2020, is projected to reach a revised size of US$9.9 Billion by 2027, growing at a CAGR of 12.6% over the analysis period 2020-2027.
Predictive Testing, one of the segments analyzed in the report, is projected to record a 12.5% CAGR and reach US$4.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumer Genomics segment is readjusted to a revised 13.2% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 16.5% CAGR
The Predictive Genetic Testing and Consumer Genomics market in the U.S. is estimated at US$1.2 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2027 trailing a CAGR of 16.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 11% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.9% CAGR.
Wellness Genomics Segment to Record 11.7% CAGR
In the global Wellness Genomics segment, USA, Canada, Japan, China and Europe will drive the 11% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$638.3 Million in the year 2020 will reach a projected size of US$1.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.5 Billion by the year 2027, while Latin America will expand at a 13.3% CAGR through the analysis period.
Select Competitors (Total 33 Featured):
- 23andMe, Inc.
- 454 Life Sciences Corporation
- Abbott Laboratories
- Advanced Genomic Solutions (AGS) Ltd.
- Affymetrix, Inc.
- Agilent Technologies, Inc.
- Amgen, Inc.
- Applied Biosystems
- ARUP Laboratories
- BGI
- Bio-Rad Laboratories, Inc.
- Cepheid
- Color Genomics, Inc.
- Cooper Surgical, Inc.
- Danaher Corporation
- EasyDNA
- F. Hoffmann-La Roche Ltd.
- Gene by Gene
- Guardant Health, Inc.
- Hologic, Inc. (Gen-Probe Incorporated)
- Illumina, Inc.
- Konica Minolta, Inc. (Ambry Genetics Corporation)
- Laboratory Corporation of America Holdings
- Mapmygenome
- Myriad Genetics, Inc.
- Myriad Genetics, Inc. (Counsyl, Inc.)
- Orig3n (Interleukin Genetics Inc.)
- Pathway Genomics
- Positive Biosciences, Ltd.
- QIAGEN
- Quest Diagnostics Incorporated
- Siemens
- Thermo Fisher Scientific, Inc.
- Xcode Life
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of COVID-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
- UNITED STATES
- CANADA
- JAPAN
- CHINA
- EUROPE
- FRANCE
- GERMANY
- ITALY
- UNITED KINGDOM
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA-PACIFIC
- AUSTRALIA
- INDIA
- SOUTH KOREA
- REST OF ASIA-PACIFIC
- LATIN AMERICA
- ARGENTINA
- BRAZIL
- MEXICO
- REST OF LATIN AMERICA
- MIDDLE EAST
- IRAN
- ISRAEL
- SAUDI ARABIA
- UNITED ARAB EMIRATES
- REST OF MIDDLE EAST
- AFRICA
IV. COMPETITION
- Total Companies Profiled: 33
For more information about this report visit https://www.researchandmarkets.com/r/d0ocx5
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
